We found that this subgroup of MNX1-rearranged adult AML samples have a unique mutational profile with a much higher rate of BCOR mutations (53%) than other AML samples (1%) as well as del(7q) AML (10%; ref. 11). The gene discussed is MNX1; the disease is acute myeloid leukemia.